文献速递复苏、休克与脓毒症创伤与烧伤

平民创伤全血止血复苏的全国性分析

Nationwide analysis of whole blood hemostatic resuscitation in civilian trauma.
PubMed 文献 · J Trauma Acute Care Surg · 2020-01-01
一句话结论在平民严重创伤出血性休克患者中,全血作为成分治疗的辅助手段与24小时死亡率、院内死亡率和主要并发症降低独立相关。

该研究基于2015-2016年创伤质量改进计划数据库,纳入年龄≥18岁、出血性休克且4小时内需输注至少1单位浓缩红细胞的成人创伤患者,比较全血联合成分治疗(WB-CT)与单纯成分治疗(CT only)的结局。WB-CT组280例,CT-only组8214例,WB-CT组24小时死亡率17% vs 25%(p=0.002),院内死亡率29% vs 40%(p<0.001),主要并发症29% vs 41%(p<0.001),住院时间更短(9 [7-12] vs 15 [10-21],p=0.011)。回归分析显示全血独立关联24小时死亡率降低(OR 0.78 [0.59-0.89],p=0.006)、院内死亡率降低(OR 0.88 [0.81-0.90],p=0.011)和主要并发症减少(OR 0.92 [0.87-0.96],p=0.013)。作者认为全血作为成分治疗的辅助手段与严重创伤平民患者复苏结局改善相关,需进一步研究评估在大量输血方案中加入全血的作用。

要点

  • 在出血性休克且4小时内需输注至少1单位浓缩红细胞的成人创伤患者中,全血联合成分治疗组24小时死亡率17% vs 单纯成分治疗组25%(p=0.002)。
  • 全血联合成分治疗组院内死亡率29% vs 单纯成分治疗组40%(p<0.001),主要并发症29% vs 41%(p<0.001)。
  • 全血联合成分治疗组住院时间9 [7-12]天 vs 单纯成分治疗组15 [10-21]天(p=0.011)。
  • 回归分析显示全血独立关联24小时死亡率降低(OR 0.78 [0.59-0.89])、院内死亡率降低(OR 0.88 [0.81-0.90])和主要并发症减少(OR 0.92 [0.87-0.96])。
  • 作者认为需进一步研究评估在大量输血方案中加入全血的作用。

适用人群与场景

  • 成人(年龄≥18岁)创伤患者,表现为出血性休克,且4小时内需输注至少1单位浓缩红细胞。

研究设计与关键结果

  • 研究类型:基于2015-2016年创伤质量改进计划数据库的分析,纳入8494例患者,其中全血联合成分治疗组280例,单纯成分治疗组8214例。
  • 全血联合成分治疗组输血量:全血1 [1-1]单位,浓缩红细胞16 [10-23]单位,新鲜冰冻血浆9 [6-16]单位,血小板3 [2-5]单位;单纯成分治疗组:浓缩红细胞15 [10-24]单位,新鲜冰冻血浆10 [6-16]单位,血小板2 [1-4]单位。
  • 人群特征:平均年龄34±16岁,男性79%,损伤严重度评分33(24-43),穿透伤63%。
  • 全血联合成分治疗组24小时死亡率17% vs 单纯成分治疗组25%(p=0.002),院内死亡率29% vs 40%(p<0.001),主要并发症29% vs 41%(p<0.001),住院时间9 [7-12]天 vs 15 [10-21]天(p=0.011)。
  • 回归分析:全血独立关联24小时死亡率降低(OR 0.78 [0.59-0.89],p=0.006)、院内死亡率降低(OR 0.88 [0.81-0.90],p=0.011)、主要并发症减少(OR 0.92 [0.87-0.96],p=0.013)。

证据类型、等级与局限

  • 证据类型:基于创伤质量改进计划数据库的分析,证据等级为治疗性,level IV。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为全血作为成分治疗的辅助手段与严重创伤平民患者复苏结局改善相关。
  • 作者认为需进一步研究评估在大量输血方案中加入全血的作用。

指南或共识出处

  • Trauma Quality Improvement Program 2015-2016

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Renewed interest in whole blood (WB) resuscitation in civilians has emerged following its military use. There is a paucity of data on its role in civilians where balanced component therapy (CT) resuscitation is the standard of care. The aim of this study was to assess nationwide outcomes of using WB as an adjunct to CT versus CT alone in resuscitating civilian trauma patients.

METHODS: We analyzed the (2015-2016) Trauma Quality Improvement Program. We included adult (age, ≥18 years) trauma patients presenting with hemorrhagic shock and requiring at least 1 U of packed red blood cells (pRBCs) within 4 hours. Patients were stratified into WB-CT versus CT only. Primary outcomes were 24-hour and in-hospital mortality. Secondary outcomes were hospital length of stay and major complications. Hierarchical logistic regression was performed to account for clustering effect within hospitals and adjusting for patient- and hospital-level potential confounding factors.

RESULTS: A total of 8,494 patients were identified, of which 280 received WB-CT (WB, 1 [1-1]; pRBC, 16 [10-23]; FFP, 9 [6-16]; platelets, 3 [2-5]) and 8,214 received CT only (pRBC, 15 [10-24]; FFP, 10 [6-16]; platelets, 2 [1-4]). Mean ± SD age was 34 ± 16 years, 79% were male, Injury Severity Score was 33 (24-43), and 63% had penetrating injuries. Patients who received WB-CT had a lower 24-hour mortality (17% vs. 25%; p = 0.002), in-hospital mortality (29% vs. 40%; p < 0.001), major complications (29% vs. 41%; p < 0.001), and a shorter length of stay (9 [7-12] vs. 15 [10-21]; p = 0.011). On regression analysis, WB was independently associated with reduced 24-hour mortality (odds ratio [OR], 0.78 [0.59-0.89]; p = 0.006), in-hospital mortality (OR, 0.88 [0.81-0.90]; p = 0.011), and major complications (OR, 0.92 [0.87-0.96]; p = 0.013).

CONCLUSION: The use of WB as an adjunct to CT is associated with improved outcomes in resuscitation of severely injured civilian trauma patients. Further studies are required to evaluate the role of adding WB to massive transfusion protocols.

LEVEL OF EVIDENCE: Therapeutic, level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Hanna K, Bible L, Chehab M, et al. Nationwide analysis of whole blood hemostatic resuscitation in civilian trauma. J Trauma Acute Care Surg. 2020. PMID: 32744830. doi:10.1097/TA.0000000000002753

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。